{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:50:11Z","timestamp":1763347811853,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cca.2012.11.027","type":"journal-article","created":{"date-parts":[[2012,12,8]],"date-time":"2012-12-08T01:43:26Z","timestamp":1354931006000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Abnormal expression of PI3K isoforms in patients with tobacco-related oral squamous cell carcinoma"],"prefix":"10.1016","volume":"416","author":[{"given":"Richa","family":"Garg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nootan K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satya N.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2012.11.027_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1586\/14737140.8.5.799","article-title":"Molecular mechanisms of head and neck cancer","volume":"8","author":"Deshpande","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.cca.2012.11.027_bb0010","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cca.2012.11.027_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2012.11.027_bb0020","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2012.11.027_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/138161210789941865","article-title":"The PKB\/AKT pathway in cancer","volume":"16","author":"Carnero","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cca.2012.11.027_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/excr.1999.4701","article-title":"Signaling by distinct classes of phosphoinositide 3-kinases","volume":"253","author":"Vanhaesebroeck","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cca.2012.11.027_bb0035","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.cca.2012.11.027_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0026-895X(24)26463-4","article-title":"Protein kinases as mediators of phosphoinositide 3-kinase signaling","volume":"57","author":"Toker","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cca.2012.11.027_bb0045","doi-asserted-by":"crossref","first-page":"L1009","DOI":"10.1152\/ajplung.2001.280.5.L1009","article-title":"Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells","volume":"280","author":"Krymskaya","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cca.2012.11.027_bb0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.emboj.7600967","article-title":"Phosphoinositide 3-kinase controls early and late events in mammalian cell division","volume":"25","author":"Garc\u00eda","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.cca.2012.11.027_bb0055","doi-asserted-by":"crossref","first-page":"19236","DOI":"10.1074\/jbc.272.31.19236","article-title":"p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes","volume":"272","author":"Chantry","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2012.11.027_bb0060","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1074\/jbc.275.16.11943","article-title":"The class II phosphoinositide 3-kinase PI3K-alpha is concentrated in the trans-Golgi network and present in clathrin-coated vesicles","volume":"275","author":"Domin","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2012.11.027_bb0065","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/bcr312","article-title":"Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?","volume":"3","author":"Fry","year":"2001","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cca.2012.11.027_bb0070","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/j.1460-2075.1995.tb07340.x","article-title":"A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p\u2013Vps15p protein sorting system","volume":"14","author":"Volinia","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.cca.2012.11.027_bb0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/138920207782446160","article-title":"The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications","volume":"8","author":"Arcaro","year":"2007","journal-title":"Curr Genomics"},{"key":"10.1016\/j.cca.2012.11.027_bb0080","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/sj.onc.1203597","article-title":"PIK3CA as an oncogene in cervical cancer","volume":"19","author":"Ma","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2012.11.027_bb0085","first-page":"3636","article-title":"Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway","volume":"62","author":"Massion","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2012.11.027_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.1207","article-title":"Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma","volume":"198","author":"Woenckhaus","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.cca.2012.11.027_bb0095","first-page":"4819","article-title":"Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia","volume":"9","author":"Miller","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cca.2012.11.027_bb0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.10962","article-title":"Frequent monoallelic deletion of PTEN and its reciprocal association with PIK3CA amplification in gastric carcinoma","volume":"104","author":"Byun","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cca.2012.11.027_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.bbrc.2012.05.079","article-title":"Deregulation of Beclin 1 in patients with tobacco-related oral squamous cell carcinoma","volume":"422","author":"Kapoor","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2012.11.027_bb0110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.sla.0000220040.66012.a9","article-title":"Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma","volume":"243","author":"Rychahou","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.cca.2012.11.027_bb0115","doi-asserted-by":"crossref","first-page":"12177","DOI":"10.1073\/pnas.0501753102","article-title":"Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo","volume":"102","author":"Takeshita","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.cca.2012.11.027_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H","article-title":"Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors","volume":"83","author":"Phillips","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.cca.2012.11.027_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(99)00118-7","article-title":"Phospatidylinositol 3-kinase expression in human breast cancer","volume":"287","author":"Gershtein","year":"1999","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2012.11.027_bb0130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1073\/pnas.0510772103","article-title":"Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase","volume":"103","author":"Kang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2012.11.027_bb0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cca.2012.11.027_bb0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbrc.2009.07.013","article-title":"Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation","volume":"387","author":"Ng","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2012.11.027_bb0145","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1073\/pnas.0702596104","article-title":"Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2012.11.027_bb0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1750-3639.2003.tb00481.x","article-title":"Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3\u2032-kinase\/protein kinase B (Akt) signal transduction pathway in glioblastomas","volume":"13","author":"Knobbe","year":"2003","journal-title":"Brain Pathol"},{"key":"10.1016\/j.cca.2012.11.027_bb0155","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1158\/0008-5472.CAN-09-3575","article-title":"Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer","volume":"70","author":"Koutros","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cca.2012.11.027_bb0160","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cca.2012.11.027_bb0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ceb.2008.12.011","article-title":"PI3K and mTOR inhibitors: a new generation of targeted anticancer agents","volume":"21","author":"Brachmann","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cca.2012.11.027_bb0170","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4161\/cc.3.10.1164","article-title":"Oncogenic mutations of PIK3CA in human cancers","volume":"3","author":"Samuels","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.cca.2012.11.027_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.cca.2012.11.027_bb0180","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1073\/pnas.0510857103","article-title":"Cancer-specific mutations in PIK3CA are oncogenic in vivo","volume":"103","author":"Bader","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2012.11.027_bb0185","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00432-010-0837-4","article-title":"Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent","volume":"136","author":"Kapoor","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.cca.2012.11.027_bb0190","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2443","article-title":"Structural comparisons of class I phosphoinositide 3-kinases","volume":"8","author":"Amzel","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cca.2012.11.027_bb0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-3-4","article-title":"Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation","volume":"3","author":"El Sheikh","year":"2003","journal-title":"BMC Clin Pathol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112005670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898112005670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:44:26Z","timestamp":1757861066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898112005670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":39,"alternative-id":["S0009898112005670"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2012.11.027","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal expression of PI3K isoforms in patients with tobacco-related oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2012.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}